Delivery Order SPE2DR25D1104-SPE2DR26FK505
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,178.75 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on November 24, 2025, with completion expected by November 25, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $10,497.46. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by December 4, 2025. The delivery order is fulfilled from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a $999,999,999.00 global...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,616.66 for Trulicity 1.5 mg/0.5 ml pen auto-injectors on December 4, 2025, with completion expected by December 5, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections valued at $2,026.98. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The contract is scheduled for completion by October 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under the company's...
- The Defense Logistics Agency awarded a $8,497.22 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen auto-injector supplies on November 7, 2025, with completion targeted for November 10, 2025. This firm fixed-price, non-set-aside delivery order represents a portion of AmerisourceBergen's broader pharmaceutical supply responsibilities under its larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,548.11 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen auto-injectors in 0.5 ml dosage units. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. No set-aside provisions were applied to this procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,096.43 to supply Trulicity 1.5 mg/0.5 ml pen auto-injectors, a diabetes medication. The contract was awarded on October 24, 2025, with an ultimate completion date of October 27, 2025, and represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors valued at $1,435.89. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors at a firm fixed price ceiling of $2,907.40. This non-set-aside delivery order, with an ultimate completion date of November 14, 2025, represents a continuation of pharmaceutical supply support under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors with a ceiling value of $2,907.40. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The order is set for completion by November 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK505Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen auto-injectors with a ceiling value of $1,162.96 and a completion date of November 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and military healthcare systems. The order will be fulfilled from the company's Pennsylvania location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. The delivery order for Trulicity, a diabetes medication, represents a typical utilization of this expansive contract vehicle to meet federal healthcare requirements for the Defense Health Agency and other government medical systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/24/25 |